🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Feliz Natal! 🎄🤶🪅

Nos dias 28 e 29 de março de 2025, São Paulo será palco da Conferência Brasileira de Câncer de Mama LACOG - GBECAM 2025 (LACOG - Latin American Cooperative Oncology Group GBECAM ). Garanta sua participação gratuita realizando a inscrição no site oficial: lacog-gbecam.com.br/evento/lacoggb….

2025 is anticipated to be the year with the highest number of phase 3 ADC trials read outs in breast oncology, with impact for all breast cancer subtypes. Here’s 8 ADC breast cancer trials expected to reshape practice in 2025:

The largest Brazilian conference in breast cancer started today - GBECAM . Julia Maués is giving us a lecture that comes with the most important lesson: nothing happens in oncology without the patient! They are why we do what we do 🤍

Abertura oficial da Conferência Brasileira de Câncer de Mama LACOG-GBECAM 2025 LACOG - Latin American Cooperative Oncology Group Luciana Landeiro, MD PhD Gustavo Werutsky

✨ Parte do grupo GBECAM. ✨

Maryam Lustberg Maryam Lustberg MD, MPH, FASCO Chief of Breast Oncology and Director of the Breast Center at Yale Cancer Center in New Haven Connecticut) sharing insights on Optimizing Post-Cancer Life Management: challenges & strategies in the journey of patients with triple-negative breast

Best of SABCS 2024 – Advanced Breast Cancer 🧬 Featuring an amazing panel: Debora Gagliato , Carlos dos Anjos, Aline Gonçalves, Andrea Shimada, Otto Metzker & Gisah Guilgen! 💬✨ #BreastCancer #SABCS2024 #Oncology

🎉 Congratulations, Renata Colombo Bonadio, MD ! Winner of the 2025 GBECAM Research Support Fund (FIP) project! We’re so proud of this amazing achievement! 🙌🔬✨

Hot Topics in Young Patients, Fertility, and Disparities in Breast Cancer: What We Learned in 2024 A powerful session with key takeaways we should keep top of mind every day. 🧠🎗️🩺 Maryam Lustberg MD, MPH, FASCO Leandro Jonata Oliveira Pedro Exman MD, PhD Laura Testa Solange Sanches JesséLopes

Starting day 2 with a key topic! Case-based discussion on metastatic ER+/HER2- breast cancer! LACOG - Latin American Cooperative Oncology Group Dr. Cristiano Resende Maryam Lustberg MD, MPH, FASCO Julia Maués Mayana Lopes, José Bines, Cristiano Pádua.

GBECAM - Maryam Lustberg on optimizing post-cancer life management GBECAM Maryam Lustberg MD, MPH, FASCO Yale Cancer Center oncodaily.com/blog/gbecam-26… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #PostCancerLifeManagement #TNBC

A few highlights from my ADC resistance talk at LACOG - Latin American Cooperative Oncology Group GBECAM 1) T-DXd works after T-DM1, diff payload, stronger ADC 2) 2nd TOP1 ADC performs inferiorly 3) Muts in TROP2 and TOP1--> resistance 4) ⬇️target occurs post T-DXd 5) New ADCs with diverse payloads needed

Honored to participate in the 2025 LACOG-GBECAM Brazilian Breast Cancer Conference - Leandro Jonata Carvalho (Leandro Jonata Oliveira) LACOG - Latin American Cooperative Oncology Group GBECAM oncodaily.com/blog/leandro-j… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc

Amazing talk by Dr Sarah Sammons at GBECAM Conference last week! Thank you so much for such great discussions and insights for future plans. We'll be waiting for you in Recife next time around! 😎🏝️

Convite para o Tumor Board do GBECAM Temos o prazer de convidá-los para o Tumor Board do GBECAM, um evento dedicado à discussão multidisciplinar de casos em oncologia mamária. Esta iniciativa visa promover a colaboração entre especialistas para otimizar a tomada de decisões e

New Brazilian real-world data from GBECAM members: only 58.7% of women with nonmetastatic ER+ breast cancer adhered to adjuvant endocrine therapy. Better QoL linked to better adherence. Urgent need for survivorship support. 🔗 Full text available ascopubs.org/doi/10.1200/GO…

TODAY: Save the Date: GBECAM Connection – May 6, 2025! 🌍 An exclusive session in English, with simultaneous translation (EN–PT) to make it accessible for all! 📅 Date: Tuesday, May 6, 2025 🕖 Time: 🇧🇷 7:00–8:30 PM (BRT) 🇮🇹 Milan: 11:00 PM (UTC+2) 🇺🇸 Boston: 6:00 PM (UTC-4) 📍